Anula Jayasuriya - Oct 8, 2024 Form 4 Insider Report for Jaguar Health, Inc. (JAGX)

Role
Director
Signature
/s/ Jonathan Wolin, Attorney-in-Fact
Stock symbol
JAGX
Transactions as of
Oct 8, 2024
Transactions value $
$0
Form type
4
Date filed
10/10/2024, 09:53 PM
Previous filing
Jul 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JAGX Stock option (right to buy) Award $0 +21K $0.00 21K Oct 8, 2024 Common Stock 21K $1.29 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the issuer's 2014 Stock Incentive Plan.
F2 The option grant was approved by the issuer's board of directors on October 8, 2024.
F3 The options will vest 100% on the first anniversary of the grant date, so long as the reporting person continues to serve on the board of directors of the issuer.